BZ vs GENI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

BZ

39.8
AI Score
VS
GENI Wins

GENI

56.4
AI Score

Investment Advisor Scores

BZ

40score
Recommendation
SELL

GENI

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BZ GENI Winner
Revenue 1.18B 669.49M BZ
Net Income 391.15M -111.58M BZ
Net Margin 33.1% -16.7% BZ
Operating Income 352.36M -151.33M BZ
ROE 13.7% -15.4% BZ
ROA 11.1% -9.9% BZ
Total Assets 3.51B 1.13B BZ
Cash 587.00M 280.56M BZ
Current Ratio 4.66 1.56 BZ
Free Cash Flow 633.95M 64.54M BZ

Relative Price Performance (Last 90 Days)

BZ 1M: +13.9% · 3M: +6.4% GENI 1M: +6.9% · 3M: +0.9%

Current Technical Phase

BZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.1 · Price: $16.41

GENI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.1 · Price: $6.54

Fundamentals Snapshot

Metric BZ GENI
Market Cap — —
Forward P/E 1.7 6.1
Trailing P/E 11.7 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.6%
Gross Margin 0.9% 0.3%
Operating Margin 0.4% -0.1%
EPS 1.39 -0.67
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, GENI is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.